SE8404130L - NEW INJECTABLE COMPOSITIONS - Google Patents

NEW INJECTABLE COMPOSITIONS

Info

Publication number
SE8404130L
SE8404130L SE8404130A SE8404130A SE8404130L SE 8404130 L SE8404130 L SE 8404130L SE 8404130 A SE8404130 A SE 8404130A SE 8404130 A SE8404130 A SE 8404130A SE 8404130 L SE8404130 L SE 8404130L
Authority
SE
Sweden
Prior art keywords
injectable compositions
microns
particles
maximum dimension
new injectable
Prior art date
Application number
SE8404130A
Other languages
Unknown language ( )
Swedish (sv)
Other versions
SE8404130D0 (en
SE460095B (en
Inventor
J H Bell
R P Haslam
A Lewis
Original Assignee
May & Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May & Baker Ltd filed Critical May & Baker Ltd
Publication of SE8404130D0 publication Critical patent/SE8404130D0/en
Publication of SE8404130L publication Critical patent/SE8404130L/en
Publication of SE460095B publication Critical patent/SE460095B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

A sterile, substantially neutral aqueous injectable suspension comprises up to approximately 80% w/v of metronidazole, the metronidazole being in the form of particles having a median maximum dimension of from 15 to 30 microns and containing not more than about 10% by weight of particles having a maximum dimension of 10 microns or less and not more than about 10% by weight of particles having a maximum dimension of 80 microns or greater.
SE8404130A 1983-08-19 1984-08-17 INJECTABLE COMPOSITION CONTAINING 1- (2-HYDROXYETHYL) -2-METHYL-5-NITROIMIDAZOLE AND PACKAGING FOR PREPARATION OF THEREOF SE460095B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838322364A GB8322364D0 (en) 1983-08-19 1983-08-19 Compositions of matter

Publications (3)

Publication Number Publication Date
SE8404130D0 SE8404130D0 (en) 1984-08-17
SE8404130L true SE8404130L (en) 1985-02-20
SE460095B SE460095B (en) 1989-09-11

Family

ID=10547557

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8404130A SE460095B (en) 1983-08-19 1984-08-17 INJECTABLE COMPOSITION CONTAINING 1- (2-HYDROXYETHYL) -2-METHYL-5-NITROIMIDAZOLE AND PACKAGING FOR PREPARATION OF THEREOF

Country Status (17)

Country Link
JP (1) JPS6067468A (en)
AU (1) AU577055B2 (en)
BE (1) BE900381A (en)
CA (1) CA1214727A (en)
CH (1) CH662812A5 (en)
DE (1) DE3430354A1 (en)
DK (1) DK165817C (en)
FR (1) FR2560043B1 (en)
GB (2) GB8322364D0 (en)
HU (1) HU192990B (en)
IL (1) IL72714A (en)
IT (1) IT1213208B (en)
LU (1) LU85511A1 (en)
NL (1) NL8402510A (en)
NZ (1) NZ209270A (en)
SE (1) SE460095B (en)
ZA (1) ZA846431B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL194638C (en) * 1986-12-19 2002-10-04 Novartis Ag Hydrosol containing solid particles of a pharmaceutically active substance and pharmaceutical preparation containing this hydrosol.
US7849856B2 (en) 2001-06-25 2010-12-14 3M Innovative Properties Company Respirator valve

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB213928A (en) * 1923-04-06 1925-07-02 Deutsche Werke Ag Improvements in or relating to compensated induction motors for single or polyphase alternating current
US3457348A (en) * 1966-06-27 1969-07-22 American Cyanamid Co Stable syringeable suspensions of parenteral drugs in complex floc form
GB1430411A (en) * 1973-04-05 1976-03-31 May & Baker Ltd Method and compositions for combating swine dysentery
US4029782A (en) * 1975-04-28 1977-06-14 Eli Lilly And Company Cefazolin suspension for parenteral administration
GB2000025A (en) * 1977-05-14 1979-01-04 Pfizer Ltd Nitroimidazole formulations
DE2932691A1 (en) * 1979-08-11 1981-04-09 Bayer Ag, 5090 Leverkusen Antimycotic tablets contg. micronised azole derivs. - together with acid and/or buffer

Also Published As

Publication number Publication date
BE900381A (en) 1985-02-18
HU192990B (en) 1987-08-28
DE3430354A1 (en) 1985-03-07
DK397084D0 (en) 1984-08-17
FR2560043A1 (en) 1985-08-30
GB8322364D0 (en) 1983-09-21
IT1213208B (en) 1989-12-14
HUT35650A (en) 1985-07-29
CH662812A5 (en) 1987-10-30
CA1214727A (en) 1986-12-02
AU3202284A (en) 1985-02-21
FR2560043B1 (en) 1988-08-05
DK165817B (en) 1993-01-25
IT8422323A0 (en) 1984-08-13
GB2145088A (en) 1985-03-20
IL72714A (en) 1988-09-30
NZ209270A (en) 1988-02-29
SE8404130D0 (en) 1984-08-17
DK397084A (en) 1985-02-20
SE460095B (en) 1989-09-11
DK165817C (en) 1993-06-21
AU577055B2 (en) 1988-09-15
GB2145088B (en) 1986-10-08
GB8420959D0 (en) 1984-09-19
JPS6067468A (en) 1985-04-17
LU85511A1 (en) 1985-04-24
NL8402510A (en) 1985-03-18
ZA846431B (en) 1985-03-27

Similar Documents

Publication Publication Date Title
ATE41308T1 (en) SUCRALFATE SUSPENSION.
IL64111A (en) 1-carboxyalkanoylindoline-2-carboxylic acids,their manufacture and pharmaceutical compositions containing them
ES2124479T3 (en) BIOCIDAL COMPOSITIONS.
GR3007845T3 (en)
ITRM920489A1 (en) PROCEDURE TO AVOID THE INSTABILITIES OF ROAD BEHAVIOR OF VEHICLES.
ATE22774T1 (en) PLANT PROTECTION PRODUCTS IN THE FORM OF MIXED DISPERSIONS.
NO832749L (en) PUMPABLE CONCENTRATED POLYMER SUSPENSIONS.
FI831230L (en) N-GLYCOSYLERADE CARBOXYLSYRAM DERIVATIVES, FOERFARANDE FOER DERAS FRAMSTAELLNING VELVES
FI872295A (en) Concentrated aqueous suspension compositions of pendimethalin
IT7967447A0 (en) AQUEOUS SUSPENSION AND PROCEDURE FOR THE MANUFACTURE OF PARTICLE CLEANING COMPOSITIONS
TW348063B (en) A pharmaceutical composition in the form of plaster containing pranoprofen
KR880013557A (en) New Ophthalmic Compositions
CA2047802A1 (en) Pharmaceutical compositions
SE8404130L (en) NEW INJECTABLE COMPOSITIONS
DE3775833D1 (en) METHYLATED CHITOSANS AND THEIR USE IN THE PRODUCTION OF PHARMACEUTICAL COMPOSITIONS.
FR2595249B1 (en) PHARMACEUTICAL COMPOSITION CONSISTING OF A SUSPENSION OF CALCIUM CARBONATE
ES2087898T3 (en) AQUEOUS ZEOLITE SUSPENSION INCLUDING A SILICONATE.
BE893025A (en) DERIVATIVES OF 1,4-THIAZANE-CARBOXILIC ACID, THEIR PREPARATION AND USE AS WELL AS THE COMPOSITIONS CONTAINING THESE DERIVATIVES.
ATE87225T1 (en) ANTIFOAM AGENTS AND THEIR USE.
IT8421331A0 (en) COMPOSITIONS AND PROCEDURE FOR THE STABILIZATION OF ANTRALIN.
PT86665A (en) PROCESS FOR THE PREPARATION OF 14.15-SUBSTITUTED LANOSTEROLS AND OF HYPOCHOLESTEROLEMIC COMPOSITIONS CONTAINING THE SAME
UA13032A (en) The liquid cleansing agent
ES8702162A1 (en) Self-emulsionable compositions based on fluorochlorohydrocarbons and phosphoric esters.
SU1207006A1 (en) PROTECTIVE ENVIRONMENT FOR LYOPHYLIZATION OF ERYTHROCYTIC DIAGNOSTICUM
KR830007066A (en) Toothpaste composition

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8404130-0

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8404130-0

Format of ref document f/p: F